S'abonner

Kidney dysfunction and fatal cardiovascular disease—an association independent of atherosclerotic events: Results from the Health, Aging, and Body Composition (Health ABC) study - 09/08/11

Doi : 10.1016/j.ahj.2007.08.012 
Rajat Deo, MD a, Christina L. Wassel Fyr, MS b, c, Linda F. Fried, MD, MPH d, e, Anne B. Newman, MD, MPH f, g, Tamara B. Harris, MD, MS h, Sara Angleman h, Christie Green, MD i, Stephen B. Kritchevsky, PhD j, Glenn M. Chertow, MD, MPH b, c, Steven R. Cummings, MD k, Michael G. Shlipak, MD, MPH l,

for the Health ABC study

a Division of Cardiology, Johns Hopkins Hospital, Baltimore, MD 
b Department of Medicine, University of California, San Francisco, CA 
c Department of Epidemiology and Biostatistics, University of California, San Francisco, CA 
d The Renal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA 
e Renal Section, VA Pittsburgh Healthcare System, Pittsburgh, PA 
f Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA 
g Division of Geriatric Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 
h Laboratory of Epidemiology, Demography and Biometry, Intramural Research Program, National Institute on Aging, Bethesda, MD 
i Division of Nephrology, Department of Medicine, University of Tennessee, Memphis, TN 
j J. Paul Sticht Center on Aging and Rehabilitation, Wake Forest Bowman Gray School of Medicine, Winston-Salem, NC 
k California Pacific Medical Center Research Institute, San Francisco, CA 
l General Internal Medicine Section, Veterans Affairs Medical Center, San Francisco, CA 

Reprint requests: Michael G. Shlipak, MD, MPH, University of California, San Francisco, General Internal Medicine Section, VA Medical Center (111A1), 4150 Clement Street, San Francisco, CA 94121.

Résumé

Background

Impaired kidney function has been associated with increased risk for death, myocardial infarction, stroke, and heart failure in high-risk populations. We evaluated whether impaired kidney function predicted risk of fatal cardiovascular disease independent of prevalent and incident cardiovascular events.

Methods

The Health, Aging, and Body Composition study is a cohort of well-functioning, elderly participants aged 70 to 79 years at entry. We measured serum cystatin C and creatinine from baseline plasma samples of 3044 participants and followed them over 6 years, examining the associations among kidney function, cardiovascular death, and incident cardiovascular events. Cystatin C was categorized as low (<0.84 mg/L), medium (0.84-1.18 mg/L), or high (≥1.19 mg/L); serum creatinine (cutoff value of ≥1.3 in women and ≥1.5 in men) and estimated glomerular filtration rate (eGFR; greater and less than 60 mL/min per 1.73 m2) were dichotomized.

Results

During follow-up, 242 cardiovascular deaths occurred, of which 69 were in participants without prior cardiovascular events; 294 incident cardiovascular events occurred including 135 myocardial infarctions and 163 strokes. Higher cystatin C concentrations were significantly associated with cardiovascular death (adjusted hazard ratio [HR] 1.70, 95% confidence interval [CI] 1.05-2.76 for the medium cystatin C group; and HR 2.24, 95% CI 1.30-3.86 for the high cystatin C group, relative to the low cystatin C group). The point estimate was of greater magnitude in the analysis that excluded prevalent cardiovascular disease (adjusted HR 2.68, 95% CI 0.94-7.70 for the medium cystatin C group; and HR 4.91, 95% CI, 1.55-15.54 for the high cystatin C group). Elevated creatinine levels (adjusted HR 1.54, 95% CI 1.02-2.33, and HR 2.28, 95% CI 1.10-4.73 among participants without a history of cardiovascular disease) were also associated with cardiovascular death. No significant association was found between low eGFR and cardiovascular death. In addition, cystatin C, low eGFR, or elevated creatinine levels were not associated with other cardiovascular events.

Conclusion

Impaired kidney function is a strong predictor of cardiovascular death, particularly among participants without prior history of cardiovascular disease.

Le texte complet de cet article est disponible en PDF.

Plan


 Health ABC was supported through the National Institute on Aging contracts N01-AG-6-2101, N01-AG-6-2103, and N01-AG-6-2106. This research was supported in part by the Intramural Research program of the NIH, National Institute on Aging.


© 2008  Mosby, Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 155 - N° 1

P. null - janvier 2008 Retour au numéro
Article précédent Article précédent
  • Biomarker analysis by fluorokine multianalyte profiling distinguishes patients requiring intervention from patients with long-term quiescent coronary artery disease: A potential approach to identify atherosclerotic disease progression
  • Paul A. Gurbel, Rolf P. Kreutz, Kevin P. Bliden, Joseph DiChiara, Udaya S. Tantry
| Article suivant Article suivant
  • Recovery of normal ventricular function in patients with dilated cardiomyopathy: Predictors of an increasingly prevalent clinical event
  • Philip F. Binkley, Amanda Lesinski, Jeanette Pohorence Ferguson, Patricia S. Hatton, Laura Yamokoski, Sheetal Hardikar, Glen E. Cooke, Carl V. Leier

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.